GleamWall
中文EN

BKYI BIO KEY INTERNATIONAL INC

Services-Prepackaged Software · Nasdaq · SEC CIK 1019034 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.0%
TTM net income YoY-40.1%
TTM EPS YoY—
Revenue 3-yr CAGR-4.8%
Net income 3-yr CAGR—

Margins

Gross margin84.4%
Operating margin-86.2%
Net margin-89.8%
FCF margin-67.5%
EBITDA margin-85.3%

Returns

ROE-94.7%
ROA-62.8%
ROIC (approx.)-108.5%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets26.0%
Debt / equity0.00x
Current ratio2.47x
Interest coverage-129.12x

Cash quality & payout

Operating cash flow / net income0.75x
Accruals ratio-15.7%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.48M$1.92M$2.15M$1.08M$1.55M$1.70M$1.61M$1.46M
Cost of revenue$143,373$245,951$376,300$271,371$357,988$464,180$279,498$262,360
Gross profit$1.34M$1.67M$1.77M$812,412$1.19M$1.23M$1.33M$1.20M
R&D expense$635,038$640,418$616,880$694,471$683,620$636,027$595,775$660,151
SG&A expense$1.52M$1.56M$1.31M$1.83M$1.40M$1.68M$1.37M$1.81M
Operating income-$820,213-$529,405-$157,713-$4.21M-$892,190-$1.08M-$640,638-$1.27M
Interest expense$4,048$27,000$27,166-$13,929$13,174$25,638$35,910$66,932
Pretax income-$886,083-$576,852-$205,037-$4.27M-$964,849-$1.17M-$736,545-$1.41M
Income tax$0$0$0$16,500$0$0$0-$22,998
Net income-$886,083-$576,852-$205,037-$4.29M-$964,849-$1.17M-$736,545-$1.38M
EBITDA-$809,640-$511,174-$142,997-$4.19M-$870,924-$1.06M-$618,856-$1.24M
EPS (basic)-4.01-0.56-0.20—-1.44-2.01-1.57—
EPS (diluted)————————
Balance sheet
Cash & equivalents$2.22M$1.38M$2.25M$2.69M$2.04M$2.28M$3.13M$437,604
Receivables$2.35M$1.73M$1.57M$1.22M$959,503$983,534$803,277$718,229
Inventory$367,063$375,740$338,397$370,879$394,176$318,538$357,842$378,307
Current assets$5.28M$3.81M$4.49M$4.54M$3.75M$4.04M$4.59M$1.89M
PP&E, net$32,051$34,804$53,035$67,751$82,557$102,499$122,986$140,198
Intangibles$662,572$718,430$774,318$830,357$886,563$942,892$1.02M$1.10M
Total assets$8.84M$7.48M$8.16M$8.30M$10.11M$10.52M$11.18M$8.62M
Current liabilities$2.14M$3.01M$3.19M$3.10M$2.96M$3.53M$3.47M$4.55M
Long-term debt—————$0$11,666$44,762
Total debt—————$0$11,666$44,762
Total liabilities$2.30M$3.15M$3.26M$3.20M$4.07M$3.66M$3.66M$4.84M
Shareholders' equity$6.54M$4.33M$4.89M$5.11M$6.05M$6.85M$7.53M$3.77M
Net debt—————-$2.28M-$3.12M-$392,842
Shares outstanding2.04M1.09M1.09M1.09M7.31M6.85M5.81M371,696
Cash flow statement
Operating cash flow-$1.43M-$845,749-$358,001-$1.83M-$1.12M-$880,012-$835,312-$514,564
Capital expenditure$7,819$0$0$4,639$1,325$1,478$4,570-$10,000
Free cash flow-$1.44M-$845,749-$358,001-$1.84M-$1.12M-$881,490-$839,882-$504,564
Investing cash flow-$7,819$0$0-$4,639-$1,325-$1,478-$4,570$10,000
Financing cash flow$2.34M$7,660-$38,179$2.46M$962,508-$35,722$3.53M-$833,560
Depreciation & amortization$10,573$18,231$14,716$19,444$21,266$21,966$21,782$23,911
Stock-based compensation$47,652$42,652$40,744$60,590$31,660$21,837$52,488$71,633

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.